Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg).
Seng Gee LimWah Wah PhyoJoanna Zhi Jie LingGavin ClohertyEmily K ButlerMary C KuhnsAnne L McNamaraVera HolzmayerJeffrey GerschWei Lyn YangJing Hieng NguJason ChangJessica TanTaufique AhmedYock Young DanYin Mei LeeGuan Huei LeePoh Seng TanDaniel Q HuangHtet Toe Wai KhineChris LeeAmy TayEdwin ChanPublished in: Alimentary pharmacology & therapeutics (2020)
On-treatment biomarker predictors were better than baseline ones, and the best predictor of HBsAg loss at 72 weeks was week 8 qHBsAg <70 IU/mL.